Functional subtypes of renal α1-adrenoceptor in spontaneously hypertensive rats with streptozotocin-induced experimental diabetic nephropathy

Kidney and Blood Pressure Research

Volumn 32, Issue 5, 2009, Pages 349-359

  Khan, Md Abdul Hye ^a,b   Sattar, Munavvar Abdul ^a   Abdullah, Nor Azizan ^c   Abdulla, Mohammed H ^a   Salman, Ibrahim M ^a   Kazi, Raisa N ^a   Swarup, K R L Anand ^a   Rathore, Hassaan A ^a   Basri, Fathihah ^a   Hussain, Nurjannah M ^a   Dewa, Aidiahmad ^a   Johns, Edward James ^d  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

1 Adrenoceptor; Diabetic nephropathy; Rat renal 1 adrenoceptor; Renal vasculature

Indexed keywords

ALBUMIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; CREATININE; SODIUM ION; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; HYPERTENSION; KIDNEY BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION;

ADRENERGIC ANTAGONISTS; AMLODIPINE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; HYPERTENSION; KIDNEY; MALE; METHOXAMINE; NOREPINEPHRINE; PHENYLEPHRINE; RATS; RATS, INBRED SHR; RECEPTORS, ADRENERGIC, ALPHA-1; STREPTOZOCIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 70350077443     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000249149     Document Type: Article

References (35)

1. Arévalo-León LE, Gallardo-Ortiz IA, Urquiza-Marin H, Villalobos-Molina R: Evidence for the role of α1 D - and α 1 A -adrenoceptors in contraction of rat mesenteric artery. Vascul Pharmacol 2003; 40: 91-96.
2. Salomonsson M, Brannstorm K, Arendshorst WJ: α1 -Adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies. Am J Physiol 2000; 278:F138-F147.
3. Villalobos-Molina R, Lopez-Guerrero JJ, Ibarra M: Alpha 1D - and alpha 1A -adrenoceptors mediate contraction in rat renal artery. Eur J Pharmacol 1997; 322: 225-227.
4. Blue DR Jr, Vimont RL, Clarke DE: Evidence for a noradrenergic innervation to-1 A -adrenoceptors in rat kidney. Br J Pharmacol 1992; 107: 414-417.
5. Abdul Sattar M, Johns EJ: α1 -Adrenoceptor subtype mediating adrenergic vasoconstriction in kidney of 2K1C Goldblatt and DOCAsalt hypertensive rats. J Cardiovasc Pharmacol 1994; 24: 420-428.
6. Sattar MA, Johns EJ: Evidence for an α1 -adrenoceptor subtype mediating adrenergic vasoconstriction in Wistar normotensive and stroke prone hypertensive rats. J Cardiovascular Pharmacol 1994; 23: 232-239.
7. Stassen FR, Mass RG, Schiffers PM, Janssen GM, De Mey JG: A positive and reversible relationship between adrenergic nerves and α1 A -adrenoceptors in rat arteries. J Pharmacol Exp Ther 1998; 284: 399-405.
8. Khan AH, Munavvar AS, Abdullah NA, Johns EJ: Influence of cisplatin-induced renal failure on the α 1 -adrenoceptor subtype causing vasoconstriction in the kidney of the rat. Eur J Pharmacol 2007; 569: 110-118.
9. Duggan KA, Hodge G, Makarious MM, Charlesworth JA: Differential efficacy of perindopril and enalapril in experimental diabetic nephropathy. Clin Exp Pharmacol Physiol 1996; 23: 608-610.
10. Lehfeld LS, Silveira LA, Ghini B, Lopes de Faria JB: Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy. Kidney Blood Press Res 2004; 27: 114-120.
11. Isogai S, Kameyama M, Iso K, Yoshino G: Protective effects of a small dose of captopril on the reduction of glomerular basement membrane anionic sites in spontaneously hypertensive rats with streptozotocin-induced diabetes. J Diabetes Complications 1998; 12: 170-173.
12. Cooper ME, Allen AJ, O'Brien RC, Macmillian PA, Clarke B, Jerums G, Doyle AE: Effects of genetic hypertension on diabetic nephropathy in the rat-functional and structural characteristics. Am J Hypertens 1988; 1: 5-10.
13. Cooper ME, Allen TJ, Jerums G, Doyle AE: Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rats. Clin Exp Pharmacol Physiol 1986; 13: 655-662.
14. Gojo A, Utsunomiya K, Tanigushi K, Yokota T, Ishizawa S, Kanazawa Y, Kurata H, Tajima N: The rho-kinase inhibitor, fasudil attenuates diabetic nephropathy in streptozotocininduced diabetic rats. Eur J Pharmacol 2007; 568: 242-247.
15. Lu Q, Yin XX, Wang JY, Gao YY, Pan YM: Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats. Acta Pharmacol Sin 2007; 28: 818-828.
16. Yin X, Zhang Y, Wu H, Zhu X, Zheng X, Jiang S, et al: Protective effect of Astragalus saponin I on early stage of diabetic nephropathy in rats. J Pharmacol Sci 2004; 95: 256-266.
17. Yin X, Zhang Y, Shen J, Wu H, Zhu X, Li L, Qiu J, et al: Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats. Acta Pharmacol Sin 2005; 26: 721-728.
18. Zhang YW, Wu CY, Cheng JT: Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expression of NF- κB and I κ B in renal cortex of streptozotocin-induced diabetic rats. J Ethnopharmacol 2007; 114: 387-392.
19. Yin X, Zhang Y, Yu J, Zhang P, Shen J, Qiu J, Wu H, Zhu X: The antioxidant effects of Astragalus saponin I protect against development of early diabetic nephropathy. J Pharmacol Sci 2006; 101: 166-173.
20. Kataya HAH, Hamza AA: Red cabbage ( Brassica oleracea ) ameliorates diabetic nephropathy in rats. eCAM 2007; DOI: 10.1093/ ecam/nem029.
21. Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, Yamasaki Y, Makino H: Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004; 53: 1831-1840.
22. Hye Khan A, Munavvar AS, Abdullah NA, Johns EJ: Cisplatin cause altered renal hemodynamics in rats: role of augmented α -adrenergic responsiveness. Exp Toxicol Pathol 2007; 53: 253-260.
23. Villalba N, Stankevicius E, Garcia-Sacristan A, Simonsen U, Prieto D: Contribution of both Ca 2+ entry and Ca 2+ sensitization to the-1 -adrenergic vasoconstriction of rat penile small arteries. Am J Physiol 2007; 292:H1157-H1169.
24. Gisbert R, Noguera MA, Ivorra MD, D'Ocon P: Functional evidence of a constitutively active population of α1 D -adrenoceptors in rat aorta. J Pharmacol Exp Ther 2000; 295: 810-817.
25. Salomonsson M, Arendshorst WJ: Calcium recruitment in the renal vasculature: norepinephrine effects on blood flow and cytosolic calcium concentration. Am J Physiol 1999; 276:F700-F710.
26. Weber LP, Macleod KM: Influence of streptozotocin diabetes on the α 1 -adrenoceptor and associated G proteins in rat arteries. J Pharmacol Exp Ther 1997; 283: 1469-1478.
27. Murray P, Pitt B, Webb RC: Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia 1994; 37: 664-670.
28. García-Sáinz JA, Vazuez-Prado J, Medina LC: α 1 -Adrenoceptors: functions and phosphorylation. Eur J Pharmacol 2000; 389: 1-12.
29. Martinez-Nieves B, Dunber JC: Vascular dilatatory responses to sodium nitropruside and α -adrenergic antagonism in female and male normal and diabetic rats. Proc Soc Exp Biol Med 1999; 222: 90-98.
30. Villalobos-Molina R, Ibarra M: α 1 -Adrenoceptors mediating contraction in arteries of normotensive and spontaneously hypertensive rats are of the α 1A or α 1D subtypes. Eur J Pharmacol 1996; 298: 257-263.
31. Ibarra M, Pardo JP, López-Guerrero JJ, Villalobos-Molina R: Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of α 1D - and α1 A -adrenoceptors in contraction. Br J Pharmacol 2000; 129: 653-660.
32. Docherty JR, O'Rourke M: The α -adrenoceptor-mediated actions of chloroethylclonidine. Gen Pharmacol 1997; 28: 197-201.
33. Lee PG, Hohman TC, Cai F, Regalia J, Helke CJ: Streptozotocin-induced diabetes causes metabolic changes and alteration in the neurotrophin content and retrograde transport in the cervical vagus nerve. Exp Neurol 2001; 170: 149-161.
34. Piascik MT, Sparks MS, Pruitt TA, Soltis EE: Evidence for a complex interaction between the subtypes of the α1 -adrenoceptor. Eur J Pharmacol 1991; 199: 279-289.
35. Garcia-Sainz JA, Vazquez-Cuevas FG, Romero-Avila MT: Phosphorylation and desensitization of α 1 D -adrenergic receptors. Biochem J 2001; 353: 603-610.